Insider trading

Period: 120 months Stock: EW Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

45 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

45 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

45 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

45 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
45 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
45 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

45 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 May 2026
Zovighian Bernard J CEO · indirect
Sold on a plan 2×
$2.83M 36,351 at 77.93
75.1%
Sold half or more
2 Apr 2026
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan 2×
$1.82M 22,680 at 80.16
51.6%
Sold half or more
25 Feb 2026
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold at will
$2.01M 24,000 at 83.84
53.0%
Sold half or more
30 May 2025
Zovighian Bernard J CEO · indirect
Sold on a plan
$1.24M 16,099 at 77.21
62.7%
Sold half or more
2 May 2024
Sold on a plan 2×
$2.49M 29,350 at 84.77
86.7%
Sold half or more
4 Apr 2024
Sold on a plan 4×
$2.71M 29,350 at 92.42
86.7%
Sold half or more
4 Mar 2024
Sold on a plan 2×
$2.54M 29,350 at 86.67
86.7%
Sold half or more
5 Feb 2024
Sold on a plan 4×
$2.57M 29,350 at 87.49
86.7%
Sold half or more
5 Jan 2024
Sold on a plan 2×
$2.14M 29,350 at 72.98
86.7%
Sold half or more
13 Dec 2023
Sold on a plan 4×
$2.19M 29,350 at 74.62
86.7%
Sold half or more
3 Nov 2023
Sold on a plan
$1.97M 29,350 at 67.18
86.7%
Sold half or more
2 Oct 2023
Sold on a plan
$2.02M 29,350 at 68.84
86.7%
Sold half or more
5 Sep 2023
Sold on a plan
$2.23M 29,350 at 75.86
86.7%
Sold half or more
10 May 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan 2×
$7.15M 80,700 at 88.54
81.5%
Sold half or more
9 May 2023
Szyman Catherine M. CVP, Critical Care
Sold on a plan
$6.72M 75,600 at 88.94
72.6%
Sold half or more
28 Apr 2023
SELLERS ROBERT W.A. SVP, Corporate Controller
Sold at will
$1.07M 12,270 at 87.20
51.1%
Sold half or more
28 Apr 2022
Marsh Martha H. Director
Sold, plan not stated
$3.10M 28,722 at 108.09
51.8%
Sold half or more
8 Feb 2022
GALLAHUE KIERAN Director
Sold, plan not stated
$3.57M 32,256 at 110.79
90.4%
Sold half or more
14 Jun 2021
Chopra Daveen CVP, Surgical Structural Heart
Sold, plan not stated
$2.40M 24,000 at 99.96
60.3%
Sold half or more
26 Oct 2020
Ullem Scott B. CVP, Chief Financial Officer
Sold, plan not stated 2×
$2.61M 33,150 at 78.81
55.0%
Sold half or more
12 Oct 2020
Ullem Scott B. CVP, Chief Financial Officer
Sold, plan not stated 2×
$2.78M 33,150 at 83.81
55.0%
Sold half or more
28 Sep 2020
Ullem Scott B. CVP, Chief Financial Officer
Sold, plan not stated
$2.59M 33,150 at 78.11
55.0%
Sold half or more
15 Sep 2020
Ullem Scott B. CVP, Chief Financial Officer
Sold, plan not stated
$2.77M 33,150 at 83.43
55.0%
Sold half or more
30 Aug 2019
Szyman Catherine M. CVP, Critical Care · indirect
Sold, plan not stated
$74.15K 334 at 222.00
100%
Sold half or more
29 Jul 2019
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold, plan not stated 2×
$4.45M 21,000 at 211.92
50.3%
Sold half or more
25 Jul 2019
SELLERS ROBERT W.A. VP, Corporate Controller
Sold, plan not stated 4×
$3.68M 17,417 at 211.57
56.3%
Sold half or more
19 Nov 2018
LINK WILLIAM J PHD Director · indirect
Sold, plan not stated 2×
$2.04M 13,578 at 149.92
69.2%
Sold half or more
5 Sep 2018
Ullem Scott B. CVP, CFO
Sold, plan not stated 3×
$3.51M 25,036 at 140.04
61.0%
Sold half or more
15 Aug 2018
Ullem Scott B. CVP, CFO
Sold, plan not stated 4×
$3.41M 25,000 at 136.52
61.0%
Sold half or more
3 Jul 2018
Ullem Scott B. CVP, CFO
Sold, plan not stated 2×
$3.64M 25,000 at 145.67
60.6%
Sold half or more
6 Jun 2018
Ullem Scott B. CVP, CFO
Sold, plan not stated 2×
$3.53M 25,000 at 141.07
60.6%
Sold half or more
9 May 2018
Ullem Scott B. CVP, CFO
Sold, plan not stated 3×
$3.37M 25,000 at 134.73
69.5%
Sold half or more
4 Apr 2018
Ullem Scott B. CVP, CFO
Sold, plan not stated 5×
$3.43M 25,000 at 137.17
69.5%
Sold half or more
28 Mar 2018
Ullem Scott B. CVP, CFO
Sold, plan not stated 3×
$3.43M 25,000 at 137.33
69.5%
Sold half or more
4 Aug 2017
BOBO DONALD E JR CVP, Heart Valve Therapy
Sold, plan not stated
$2.90M 25,000 at 116.00
56.0%
Sold half or more
3 May 2017
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$5.39M 49,100 at 109.71
62.1%
Sold half or more
28 Apr 2017
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$5.39M 49,100 at 109.78
62.1%
Sold half or more
27 Apr 2017
Zovighian Bernard J CVP, Surgical Heart Valves
Sold, plan not stated
$1.97M 18,050 at 109.21
65.4%
Sold half or more
15 Mar 2017
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated
$4.62M 49,100 at 94.03
61.6%
Sold half or more
16 Feb 2017
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$4.40M 49,100 at 89.63
61.6%
Sold half or more
13 Jan 2017
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$4.77M 49,100 at 97.08
61.6%
Sold half or more
19 Dec 2016
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated
$4.52M 49,100 at 91.96
61.6%
Sold half or more
29 Nov 2016
GALLAHUE KIERAN Director · indirect
Bought
$253.90K 3,000 at 84.63
98.6%
First buy on file
22 Nov 2016
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 3×
$4.16M 49,100 at 84.67
61.6%
Sold half or more
27 Oct 2016
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 4×
$4.56M 49,100 at 92.77
61.6%
Sold half or more
Showing 1–45 of 45.